U.S. Steel announced Monday that it plans to invest up to $2.5 billion to modernize its Mon Valley Works facilities near Pittsburgh. The company said the project will protect thousands …
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …